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Abstract
Background: Hospitalisation is often harmful for people with dementia and results in high societal costs, so
avoidance of unnecessary admissions is a global priority. However, no intervention has yet reduced admissions of
community-dwelling people with dementia. We therefore aimed to examine hospitalisation rates of people with
dementia and whether these differ from people without dementia and to identify socio-demographic and clinical
predictors of hospitalisation.
Methods: We searched MEDLINE, Embase, and PsycINFO from inception to 9 May 2019. We included observational
studies which (1) examined community-dwelling people with dementia of any age or dementia subtype, (2)
diagnosed dementia using validated diagnostic criteria, and (3) examined all-cause general (i.e. non-psychiatric)
hospital admissions. Two authors screened abstracts for inclusion and independently extracted data and assessed
included studies for risk of bias. Three authors graded evidence strength using Cochrane’s GRADE approach,
including assessing for evidence of publication bias using Begg’s test. We used random effects meta-analysis to
pool estimates for hospitalisation risk in people with and without dementia.
Results: We included 34 studies of 277,432 people with dementia: 17 from the USA, 15 from Europe, and 2 from
Asia. The pooled relative risk of hospitalisation for people with dementia compared to those without was 1.42
(95% confidence interval 1.21, 1.66) in studies adjusted for age, sex, and physical comorbidity. Hospitalisation rates
in people with dementia were between 0.37 and 1.26/person-year in high-quality studies. There was strong
evidence that admission is associated with older age, and moderately strong evidence that multimorbidity,
polypharmacy, and lower functional ability are associated with admission. There was strong evidence that
dementia severity alone is not associated.
Conclusions: People with dementia are more frequently admitted to hospital than those without dementia,
independent of physical comorbidities. Future interventions to reduce unnecessary hospitalisations should
target potentially modifiable factors, such as polypharmacy and functional ability, in high-risk populations.
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Background
The number of older people is expected to rise through-
out the century, with the number of people with demen-
tia rising in parallel [1]. Hospital admissions can be
harmful and distressing for people with dementia who
are less likely to receive adequate pain relief [2], more
likely to receive potentially harmful medication [3], have
a higher risk of delirium than those without dementia
[4], and commonly decline functionally during admis-
sion [5]. Avoidable admissions are more frequent for
people with dementia [6] and readmission is common
[7]. Admissions are costlier for people with dementia
than those without [8], and pressures on hospitals to re-
duce admission length could also mean that people with
dementia are prematurely discharged from hospital into
long-term care [9].
In this systematic review, we aimed to examine the
rates of all general hospitalisations of people with de-
mentia, whether these differ from those without demen-
tia, and to identify socio-demographic and clinical
predictors of admission. Understanding these would help
to plan services for future increasing numbers of people
with dementia. Previously designed interventions to re-
duce hospitalisations in people with dementia have not
been found to be effective [10]. Identifying admission
predictors may elucidate modifiable risk factors which
future interventions could target in populations most
likely to benefit.
Aims
The following are the aims of the study:
 To compare hospitalisation risk in people with
dementia to people without dementia
 To identify general hospital admission rates of
people with dementia
 To examine demographic or clinical factors
associated with higher hospital admission risk
Methods
We prospectively registered the study protocol with
PROSPERO (registration number CRD42018091722)
(Additional file 2).
Search strategy
We searched MEDLINE, Embase, and PsycINFO, in-
cluding grey literature. The initial search was completed
on 18 April 2018 and updated on 22 October 2018 and
9 May 2019 with no date or language restrictions. The
search terms related to people with dementia, hospital-
isation, and observational studies, using the SIGN filters
for observational studies; the full search strategy is in
Additional file 1: Table S1. We hand-searched included
papers’ reference lists and contacted experts in the field
to ensure a comprehensive review.
Inclusion and exclusion criteria
We included observational studies which:
 Examined populations of people with dementia (any
age or dementia subtype)
 Included clinical, research, or register populations of
people with dementia, diagnosed using validated
diagnostic criteria, e.g. International Statistical
Classification of Diseases and Related Health
Problems 10th revision, Diagnostic and Statistical
Manual of Mental Disorders 5th edition, National
Institute of Neurological and Communicative
Disorders and Stroke, and the Alzheimer’s Disease
and Related Disorders criteria
 Examined all-cause general (i.e. non-psychiatric)
hospital admissions, providing sufficient data to
examine the hospitalisation rates or potential risk
factors
We excluded papers which:
 Examined populations who predominantly resided in
long-term nursing care facilities
 Did not adequately delineate dementia, e.g. defined
dementia by cognitive test score cut-off or solely by
acetylcholinesterase inhibitor prescription. We in-
cluded studies which supplemented register-derived
dementia diagnosis by using medication prescription
as an additional marker of dementia status
 Studied general populations of older people when it
was impossible to separate out those with dementia
 Recruited study participants upon hospitalisation,
as this prevents identification of factors leading to
hospitalisation
Screening papers
After excluding duplicate papers, one researcher (HS)
screened the titles and abstracts using the eligibility cri-
teria. A random 10% sample was independently reviewed
for inclusion by a second researcher (JC); initial con-
cordance regarding the study inclusion was 87%, and
disagreements were resolved by a discussion with a third
researcher (AS). Consensus on the inclusion of all stud-
ies was agreed by two researchers (HS, AS) with any dis-
agreements resolved in a discussion with a third (GL).
Data extraction and synthesis
Where available, the following information was extracted
from included studies using a pre-piloted data extraction
form (Additional file 1: Table S2): author, year and country
of setting, participant number, mean age, sex distribution,
Shepherd et al. BMC Medicine          (2019) 17:130 Page 2 of 13
method of diagnosis, study length and average follow-
up time, average severity of dementia. Extracted out-
come data were adjusted relative risk of hospitalisa-
tion in people with dementia compared to people
without dementia and covariates included in fully ad-
justed models; percentage or rate of hospitalisation in
people with dementia; socio-demographic or clinical
factors examined as potential predictors of hospital
admission; classification of factors and relative risk for
their association with admission and covariates in-
cluded in relative risk models. Two authors (HS and
AS) independently extracted the outcome data.
We extracted data on admissions where the rate (per
person-years (py)) or percentage of participants admitted
to hospital was presented. Where the rate or proportion
admitted was not provided, but raw data was available,
we calculated the hospitalisation rate (number of hospi-
talisations/py) and/or percentage of participants admit-
ted during study follow-up.
We prioritised obtaining the risk estimates provided
for all-cause hospitalisation and, where this was not
available, for admissions defined as preventable or
ambulatory care sensitive conditions (ACSC), or for
emergency rather than elective hospital admissions.
Admissions caused by, for example, angina, infection,
dehydration, or diabetes are deemed potentially avoid-
able, as proactive community care could prevent the
need for a hospital stay [11, 12]. For studies with un-
clear data, we requested clarification directly from the
study authors and included them in our primary ana-
lyses if this was received.
Data analysis
Quality assessment and analysis
Two researchers (HS, AS) assessed the risk of bias in in-
dividual papers using a modified version of the
Newcastle-Ottawa Scale (NOS) for assessing the quality
of cohort studies [13]. This considered definition of ex-
posure, method of outcome ascertainment, selection and
measurement bias, and confounding. Concordance on
quality rating criteria was 89%, and consensus was
reached through discussion in cases of disagreement on
individual rating criteria. Full details of ratings are in
Additional file 1: Table S3.
Evidence grading
We then used the Cochrane Collaboration’s Grading of
Recommendations, Assessment, Development and
Evaluation (GRADE) approach to rate the confidence in
the estimates given [14]. Grades of high, moderate, low,
or very low were allocated based on the research team’s
(AS, HS, GL) assessment of seven criteria: (1) risk of
bias in individual studies assessed using NOS, (2) incon-
sistency (unexplained heterogeneity of results or non-
overlapping 95% confidence intervals across studies), (3)
indirectness (limited generalisability of the study popula-
tions), (4) imprecision (number of study participants and
confidence intervals (CI) around the effect), (5) evidence
of publication bias, (6) large magnitude of effect, and (7)
evidence of dose-response relationship. Strength of evi-
dence was graded down if factors 1–5 were noted and
graded up if factor 6 or 7 was seen. To rate the preci-
sion, we performed a power calculation to find the num-
ber of participants needed to find a hospitalisation rate
of 37%, as 0.37 hospitalisations/py was the lowest rate
extracted from a paper at low risk of bias according
to NOS, with 80% power and a significance level of
5%. Consequently, studies comprising > 349 partici-
pants with dementia were classed as precise. To rate
the publication bias, we used Begg’s test when three
or more studies measured an exposure in the same
way, with p ≤ 0.10 indicating risk of publication bias
[15], using STATA 14.
Statistical analysis
We provide a narrative synthesis of findings from the in-
cluded studies. For estimates of the risk of hospitalisa-
tion for people with dementia compared to those
without in studies which adjusted for at least age, sex,
and physical comorbidity, we used random effects meta-
analysis to pool the results. Random effects models are
appropriate where there is potential heterogeneity in
study populations [16] and allows a combination of dif-
ferent measures of relative risk, e.g. hazard ratio and
odds ratio [17]. We measured heterogeneity between
studies using the I2 statistic and considered a priori that
I2 > 50% indicated substantial heterogeneity. We judged
we were unable to meta-analyse the findings on predic-
tors of hospital admission as these frequently used het-
erogeneous exposure measures.
Results
We found 34 papers including a total of 277,432 people
with dementia. The Preferred Reporting Items for Sys-
tematic Review and Meta-Analysis (PRISMA) diagram
(Fig. 1) describes the results of the search and reasons
for excluding studies [18]. Thirty-four included papers
reported data from 1991 to 2016 and comprised 17 from
the USA, five from England, three from France, three
from Sweden, two from Finland, and one each from
Taiwan, Germany, Hong Kong, and Scotland (Table 1).
Five papers studied sub-populations: two were people
with dementia at end of life, and one each of people with
dementia and cancer, people with dementia and intellec-
tual disability, and people with dementia and dysphagia,
and we considered these separately.
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Comparison to people without dementia
Six studies examined the risk of hospital admission in
people with dementia compared to people without de-
mentia, adjusting for at least age, sex, and physical comor-
bidity. Relative risk (RR) estimates in these papers ranged
from 1.08 to 2.3. Figure 2 presents pooled relative risk es-
timate for hospitalisation in people with dementia com-
pared to those without (RR = 1.42 (95% CI 1.21, 1.66), p <
0.001, I2 = 86.3%). There was a consistent direction of ef-
fect, and estimates were of similar magnitude. Begg’s test
indicated a low risk of bias, so the overall strength of this
evidence was graded as high (full data on the assignment
of GRADE evidence strength is in Additional file 1: Table
S4). Four other studies [23, 34, 41, 46] did not adjust for
comorbidity and two of these found notably higher rela-
tive risk estimates (3.68 and 4.19), but we did not include
these in our meta-analysis as we wished to examine the
hospitalisation risk accounting for the potential
confounding effect of physical illness; we were unable to
include one other study which did not provide a specific p
value or confidence interval [44].
Two studies examined hospitalisation risk for people
with dementia at the end of life with one Taiwanese
register study of people in the last year of life reporting
RR for admission 1.14 (0.91–1.41) and the other study of
Finnish people with dementia in the final 2 years of life
showing lower admission risk (RR = 0.33 (0.31–0.35)).
There was low confidence in the evidence as the studies
are of moderate and low quality respectively, and they
present contradictory estimates [47, 48].
Rates of hospitalisation per year
Table 2 displays the rates of hospital admissions in
people with dementia. The studies with the lowest risk
of bias found the rate to be between 0.37/py and 1.26/
py. Among studies that used research cohorts or clinical
Fig. 1 PRISMA flow diagram of included studies
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samples, the rate ranged from 0.16/py to 0.48/py,
whereas in studies using national registers, the rate
ranged from 0.23/py to 1.26/py. Where available, the
percentage of participants hospitalised was also ex-
tracted (Additional file 1: Table S5), and in four studies
at low risk of bias which followed participants for 1 year,
26–65% of study participants were admitted.
Risk factors associated with hospitalisation
Figure 3a and b show the associations between socio-
demographic and clinical factors and hospitalisation
in people with dementia, and each risk factor has
been allocated a grade according to the confidence in
the estimates. Full detail of the criteria used to assign
GRADE levels of evidence strength for each risk fac-
tor is in Additional file 1: Table S6.
Factors relating to the person with dementia associated
with admission
Older age was consistently associated with risk of hospi-
talisation across six studies; the odds ratio (OR) for
hospitalisation with each additional year of age was OR =
1.02 in one study and OR = 1.04 in another [12, 30], and
findings were consistent when considering people aged
> 95 compared to < 75 (rate ratio = 1.66) [21]. After con-
sidering the quality of individual studies, overall
consistency, and absence of evidence of publication bias
(p = 0.60), we rated confidence in the effect of older age
on increasing hospitalisation risk as high.
Having multimorbidities was associated with hospital-
isation across six studies. A consistently large effect in-
creased confidence in the finding, and there was no
evidence of publication bias (p = 0.60). However, point
estimates and confidence intervals around estimates var-
ied widely, for instance, having other illnesses compared
to none increased odds of hospitalisation hazard ratio
(HR) = 1.28 in one study, OR = 1.47 in another, and HR =
1.87 in the third [37–39]. Therefore, confidence was
graded as moderate.
There was moderate confidence in the association of
lower level of functional ability with hospitalisation risk
as four studies found a consistent direction of results
with moderate magnitude (RR = 1.08 to 1.27), indicating
that less independence contributed to a higher risk of
hospitalisation. Similarly, the use of ≥ 7 (compared to 0–
3) medications was significantly associated with a higher
risk of admission in one high-quality (i.e. low risk of
bias) study (HR = 1.32), and there was evidence of a
dose-response effect [34], resulting in moderate confi-
dence. There was also moderate confidence in the find-
ing that severity of dementia was not associated as three
studies at low risk of bias consistently found no effect of
dementia severity on hospitalisation [37, 38, 51].
Factors relating to the primary caregiver associated with
admission
There was low or very low confidence in all factors relat-
ing to the caregiver as only one study examined each
association.
Fig. 2 Forest plot of studies examining relative risk of hospitalisation for people with dementia compared to those without dementia, adjusted
for age, sex, and physical comorbidity. Note: weights are derived from random effects meta-analysis
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Discussion
This is the first comprehensive systematic review of the
rates and risk factors for hospitalisation in people with
dementia. We found with high confidence an increased
rate of hospitalisation of people with dementia com-
pared to people without dementia. The pooled relative
risk of hospitalisation for people with dementia com-
pared to those without was 1.42 (95% CI 1.21–1.66) in
studies adjusted for age, sex, and physical comorbidity.
The increased risk of hospitalisation of people with de-
mentia, in moderate or high-quality studies, ranged from
1.08 to 2.30. This wide range suggests that hospitalisa-
tion risk may be modified by differing healthcare
provision. High-quality studies found general hospital
admission rates for people with dementia to be between
0.37 and 1.26/py. There is strong evidence that older
age is associated with admission and moderate evidence
that presence of physical comorbidities, having a lower
functional level and taking ≥7 medications, is associated
with admission, while there was strong evidence that
dementia severity alone is not associated with
hospitalisation.
The organisation of health and social systems in differ-
ent countries may affect hospitalisation risk, or differences
in the relative risk for those with and without dementia
could be due to the adjustments in analyses. One study
that did not adjust for physical comorbidities found a risk
of OR = 3.68 for people with dementia compared to those
without, suggesting that worse physical illness explains
part of the increased hospitalisation risk of people with
dementia [52]. This study also analysed the hospitalisation
risk according to the numbers of chronic conditions and
found that dementia increased the risk of admission
whether or not people had other long-term illnesses, no
Table 2 Hospitalisation rates of people with dementia
Bold outline indicates studies with lowest risk of bias
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other long-term conditions (RR = 5.92, 5.60–6.27), or five
(RR = 2.87, 2.71–3.04). The risk did not increase with
each additional comorbid condition. Evidence for the
association of dementia and hospitalisation risk at the
end of life was low strength. People with dementia
near end of life are usually very ill with multiple
health problems, but families caring for someone with
dementia at the end of life may wish to avoid hospi-
talisation because of the distress it can cause, which
could explain varying results.
The variation in findings on hospitalisation rates (0.37
to 1.17/py) could be partly explained by the nature of
the participant cohorts. Research cohort participants are
often healthier than non-participants [53] and are sub-
ject to attrition of study participants; death is a common
cause of attrition in studies of older populations [54].
Cohort studies may therefore become less representative
over time and selectively include healthier participants.
Lower hospitalisation rates could also be due to the
method of outcome ascertainment, for example, asking
family carers and patients about past admissions risks
recall bias, whereas extracting data from a national data-
base or register is likely to be more complete. Therefore,
the highest rate of 1.17 admissions/py [43] may be the
most reliable due to the large sample size and outcome
derivation from a national register. Areas with more
Fig. 3 a Association of demographic characteristics of people with dementia or caregivers and hospitalisation: relative risk of admission and
confidence in evidence. b Association of clinical characteristics of people with dementia and hospitalisation: relative risk of admission and
confidence in evidence. Note: full information on risk factor classification and evidence grading is in Additional file 1: Table S6
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older people have lower emergency admission rates
among older people [55] suggesting services are more
integrated and prioritise community-based and ambula-
tory healthcare for older populations in these areas. Al-
ternatively, there could be higher thresholds for
emergency admissions due to the larger number of older
people.
There is high confidence in the effect of older age, a
risk factor which is unmodifiable. People with multimor-
bidities are unsurprisingly at higher risk of admission,
but in one study, multimorbidity was associated with a
higher risk of conditions judged as potentially manage-
able within primary care [12]. An earlier systematic re-
view of reasons for admissions for people with dementia
found that they are more likely to have been admitted to
hospital for falls, fractures, and respiratory and uro-
logical infections than inpatients without dementia [56],
so falls prevention and early recognition and manage-
ment of respiratory and urinary tract infections and de-
lirium may be valuable future intervention strategies.
People with dementia often take many medications to
manage existing comorbidities, and our study found
moderate evidence that taking ≥ 7 medications increases
the risk of hospitalisation. The study examining poly-
pharmacy adjusted for patient comorbidities, suggesting
that medication use may contribute to elevated hospital-
isation risk independent of multimorbidity; potentially
inappropriate prescribing is common in older people
without dementia and associated with a higher risk of
hospitalisation [57]. Polypharmacy is a potentially modi-
fiable risk factor, and while this may partially reflect the
severity or number of illnesses a patient has, it may be
that some of the drugs individually or when given to-
gether are causing more harm than good. It may be that
medication is reviewed less in people with dementia, and
they remain on medications when no longer needed.
Drug interactions are more likely with each drug taken
[58] and are more likely to be harmful in older patients
[59]. Non-adherence to medications may mean that
medication is judged to be ineffective and more is added,
or a person with dementia may accidentally take too
much medication; both could increase the risk of
harmful drug interaction in this population. A recent
randomised controlled trial indicated that community-
based deprescribing can be undertaken safely in older
people without dementia, so it should be considered
whether this could safely extend to people with de-
mentia [60].
Having a lower functional ability was also associated
with hospitalisation. Functional ability refers to basic
tasks such as washing, and more intricate tasks such as
cooking. In people with dementia, it can be difficult to
ascertain whether loss of functionality is due to a com-
bination of comorbidities, side effects of medication, or
dementia. For instance, decreased ability to prepare food
in people with dementia could lead to dangerous levels
of malnutrition, dehydration, or weight loss [61], and
therefore acute hospitalisation. Further loss of function
could lead to an increase in the level of care needed to
keep someone in the community and a decrease in the
ability to seek and use appropriate help. Regarding de-
mentia severity, we had moderate confidence that this
was not associated, suggesting that it is a combination of
physical and cognitive impairment and lack of external
support, which increases admission risk, rather than
cognitive impairment alone.
In addition to the risk posed by each individual risk
factor, factors may interact with each other. It might be
expected that people with dementia and at least one
other comorbid condition are older than those with no
comorbidities, take medication for their illnesses, and
have a lower functional ability, therefore increasing their
hospitalisation risk. Other studies have found that poly-
pharmacy alone is associated with detrimental effects on
functioning [62], which could further increase the risk of
hospitalisation in this population. Rudolph et al. [37]
discuss the theory of a multiplicative effect of risk
factors and suggest patients with more than one risk
factor comprise a high-risk group should be priori-
tised as recipients of future interventions to reduce
hospitalisation.
Strengths and limitations
The comprehensive data search and thorough method-
ology of this review avoids subjectivity of data extraction
and limits the risk of significant evidence being missed.
During the initial screening process, a sample of eligible
papers was reviewed independently by a second re-
searcher to ensure the robustness of the application of
inclusion criteria. Similarly, the risk of bias was reviewed
independently by a second researcher, and grades of evi-
dence were based on research team consensus using the
gold standard Cochrane approach. Our use of the
PRISMA checklist ensured standardised reporting [18].
This review has limitations which mainly relate to the
limitations of included studies. We were only able to
examine papers from some countries, and different pat-
terns of admission may exist elsewhere in the world.
Studies of solely care home populations were excluded;
therefore, the results are not generalizable to those living
in long-term care and may only be applicable to
community-dwellers. However, as two thirds of people
with dementia live in the community [9], the results
have the potential to inform care of a large proportion
of the people currently living with dementia. In addition,
we did not include studies whose population consisted
of hospitalised patients, as they were already likely to be
more unwell than those in the community. We therefore
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expected that re-admission rates would be higher in this
patient group and risk factors for re-admission may dif-
fer from those for the first admission, and therefore not
apply to the wider community-dwelling population.
However, some risk factors for readmission reported in
other studies may apply to the first hospitalisation.
When extracting the results, we focussed on “all-cause”
hospitalisation and used the definition of hospitalisation
provided by each study and studies may have defined
this differently. Similarly, we used data for “avoidable”
hospitalisation when all-cause hospitalisation data was
not provided, and these definitions differed between
studies. Avoidable admissions were termed “primary care
sensitive” by Pimouguet, “ambulatory care sensitive” by
Thorpe, “preventable” by Bynum, and “unplanned” or
emergency by Mueller and Sommerlad [11, 12, 34, 41,
52]. Exactly which conditions fall into these categories
varies, although there is a consensus that it comprises
conditions which could be treated in the home or by pri-
mary care. It may be that only a rigorous randomised
controlled trial with a well-designed intervention can de-
termine the extent to which admissions are avoidable.
Potential risk factors were classified in different ways be-
tween included studies, which prohibited combining es-
timates using meta-analysis. Finally, all non-randomised
studies are susceptible to selection bias and residual con-
founding, so causality cannot be proven from observa-
tional studies.
Conclusions
This review finds hospital admission rates among people
with dementia to be between 0.37/py and 1.26/py and
strong evidence that people with dementia have 1.42
times higher risk of hospitalisation compared to people
without dementia. Our evidence on admission rates of
people with dementia informs policymakers aiming to
ensure appropriate current and future provision of hos-
pital care for people with dementia. Our study identifies
people with dementia at high risk of hospitalisation—
those who are older with physical comorbidities—and
suggests that reducing polypharmacy and ameliorating
functional impairment potentially will reduce admission
risk. This informs clinicians treating people with demen-
tia and future interventions aiming to reduce hospitalisa-
tion of people with dementia. There are indications of
other potentially modifiable hospitalisation risk factors,
but we were unable to make confident conclusions so
rated them as low or very low due to the lack of evi-
dence; these may warrant further detailed research.
Identifying modifiable risk factors for hospital admission
and devising effective approaches to address these have
huge potential to improve the lives of people affected by
dementia.
Additional files
Additional file 1: Table S1. Full list of search terms. Table S2. Full data
extracted from included studies and full references. Table S3. Quality
rating criteria and scores for included studies. Table S4. Risk of
hospitalisation in people with dementia compared to people without
dementia: full details of GRADE rating of evidence strength. Table S5.
Percentage of study participants hospitalised in the study period. Table
S6. Association of potential risk factors with hospitalisation in people
with dementia: full details of GRADE rating of evidence strength for risk
factors. (DOCX 147 kb)
Additional file 2: Study protocol. (PDF 100 kb)
Abbreviations
ACSC: Ambulatory care-sensitive conditions; CI: Confidence interval;
GRADE: Grading of Recommendations, Assessment, Development and
Evaluation; HR: Hazard ratio; NOS: Newcastle-Ottawa Scale; OR: Odds ratio;
Py: Person-years; RR: Relative risk
Acknowledgements
None
Authors’ contributions
AS and GL conceived the idea for this study. HS conducted the search. HS,
AS, and GL interpreted the data and drafted the manuscript and figures. JC
conducted the quality check on inclusion criteria. AS performed the statistical
tests. All authors read and approved the final manuscript.
Funding
This work was supported by the University College London Dementia
Scholarship 2017 (HS) and a grant from the Wellcome Trust (200163/Z/15/Z)
(AS). AS and GL are supported by the University College London Hospitals
NIHR Biomedical Research Centre.
The authors analysed the results and prepared this manuscript
independently of the funding bodies. The views and opinions expressed
therein are those of the authors and do not necessarily reflect those of the
NHS, the NIHR, or the Wellcome Trust. The funders had no role in the study
design, data collection and analysis, decision to publish, or preparation of
the manuscript.
Availability of data and materials
All data generated or analysed during this study are included in the
published articles and its additional files.
Ethics approval and consent to participate
No ethical approval was required for this systematic review of existing
published literature.
Consent for publication
Not applicable
Competing interests
All authors have completed the ICMJE uniform disclosure form at http://
www.icmje.org/conflicts-of-interest/ and declare HS reports funds from the
UCL Dementia Scholarship 2017. GL has grants from the National Institute
for Health Research (NIHR)/Economic and Social Research Council, NIHR
Health Technology Assessment and Alzheimer’s Society and is supported by
the North Thames NIHR Collaboration for Leadership in Applied Health
Research and Care. AS reports grants from the Wellcome Trust. GL and AS
are supported by the University College London Hospitals NIHR Biomedical
Research Centre.
Received: 28 March 2019 Accepted: 14 June 2019
References
1. Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et
al. Dementia prevention, intervention, and care. Lancet. 2017;390:2673–734.
https://doi.org/10.1016/S0140-6736(17)31363-6.
Shepherd et al. BMC Medicine          (2019) 17:130 Page 11 of 13
2. Lichtner V, Dowding D, Allcock N, Keady J, Sampson EL, Briggs M, et al.
The assessment and management of pain in patients with dementia in
hospital settings: a multi-case exploratory study from a decision making
perspective. BMC Health Serv Res. 2016;16:427. https://doi.org/10.1186/
s12913-016-1690-1.
3. White N, Leurent B, Lord K, Scott S, Jones L, Sampson EL. The management
of behavioural and psychological symptoms of dementia in the acute
general medical hospital: a longitudinal cohort study. Int J Geriatr
Psychiatry. 2017;32:297–305. https://doi.org/10.1002/gps.4463.
4. D JR, NO A, Ó-R C, J C, M L, J MF, et al. Delirium in an adult acute hospital
population: predictors, prevalence and detection 2012. https://doi.org/10.
1136/bmjopen-2012.
5. Sager MA, Rudberg MA, Jalaluddin M, Franke T, Inouye SK, Landefeld CS, et
al. Hospital Admission Risk Profile (HARP): identifying older patients at risk
for functional decline following acute medical illness and hospitalization. J
Am Geriatr Soc. 1996;44:251–7. https://doi.org/10.1111/j.1532-5415.1996.
tb00910.x.
6. Wolf D, Rhein C, Geschke K, Fellgiebel A. Preventable hospitalizations
among older patients with cognitive impairments and dementia. Int
Psychogeriatrics. 2018:1–9. https://doi.org/10.1017/S1041610218000960.
7. Pickens S, Naik AD, Catic A, Kunik ME. Dementia and hospital readmission
rates: a systematic review. Dement Geriatr Cogn Dis Extra. 2017;7:346–53.
https://doi.org/10.1159/000481502.
8. Zhu CW, Cosentino S, Ornstein K, Gu Y, Scarmeas N, Andrews H, et al.
Medicare utilization and expenditures around incident dementia in a
multiethnic cohort. J Gerontol A Biol Sci Med Sci. 2015;70:1448–53. https://
doi.org/10.1093/gerona/glv124.
9. Department of Health. Living well with dementia: a National Dementia
Strategy 2009.
10. Phelan EA, Debnam KJ, Anderson LA, Owens SB. A systematic review of
intervention studies to prevent hospitalizations of community-dwelling
older adults with dementia. Med Care. 2015;53:207–13.
11. Pimouguet C, Rizzuto D, Fastbom J, Lagergren M, Fratiglioni L, Xu W.
Influence of incipient dementia on hospitalization for primary care sensitive
conditions: a population-based cohort study. J Alzheimers Dis. 2016;52:213–
22. https://doi.org/10.3233/JAD-150853.
12. Thorpe J, Van Houtven C, Sleath B, Thorpe C. Rural-urban differences in
preventable hospitalizations among community-dwelling veterans with
dementia. J Rural Health. 2010;26:146–55. https://doi.org/10.1111/j.1748-
0361.2010.00276.x.
13. Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. Newcastle-
Ottawa quality assessment scale case control studies 2014.
14. Iorio A, Spencer FA, Falavigna M, Alba C, Lang E, Burnand B, et al. Use of
GRADE for assessment of evidence about prognosis: rating confidence in
estimates of event rates in broad categories of patients. BMJ. 2015;350:h870.
https://doi.org/10.1136/BMJ.H870.
15. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test
for publication bias. Biometrics. 1994;50:1088–101.
16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials.
1986;7:177–88. https://doi.org/10.1016/0197-2456(86)90046-2.
17. Fu R, Gartlehner G, Grant M, Shamliyan T, Sedrakyan A, Wilt TJ, et al.
Conducting quantitative synthesis when comparing medical interventions:
AHRQ and the effective health care program. J Clin Epidemiol. 2011;64:
1187–97. https://doi.org/10.1016/j.jclinepi.2010.08.010.
18. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred Reporting Items for
Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med.
2009;6(7):E1000097. https://doi.org/10.1371/journal.pmed1000097.
19. Albert SM, Costa R, Merchant C, Small S, Jenders RA, Stern Y. Hospitalization
and Alzheimer’s disease: results from a community-based study. J Gerontol
A Biol Sci Med Sci. 1999;54:M267–71.
20. Aupperle P, Coyne A. Primary vs subspecialty care: a structured follow-
up of dementia patients and their caregivers. Am J Geriatr Psychiatry.
2000;8:167–70.
21. Browne J, Edwards D, Rhodes K, Brimicombe D, Payne R. Association of
comorbidity and health service usage among patients with dementia in the
UK: a population-based study. BMJ Open. 2017;7:e012546. https://doi.org/10.
1136/bmjopen-2016-012546.
22. Brüggenjürgen B, Andersohn F, Ezzat N, Lacey L, Willich S. Medical
management, costs, and consequences of Alzheimer’s disease in Germany:
an analysis of health claims data. J Med Econ. 2015;18:466–73. https://doi.
org/10.3111/13696998.2015.1014090.
23. Bynum JPW, Rabins PV, Weller W, Niefeld M, Anderson GF, Wu AW. The
relationship between a dementia diagnosis, chronic illness, medicare
expenditures, and hospital use. J Am Geriatr Soc. 2004;52:187–94.
24. Callahan C, Arling G, Tu W, Rosenman M, Counsell S, Stump T, et al.
Transitions in care for older adults with and without dementia. J Am
Geriatr Soc. 2012;60:813–20. https://doi.org/10.1111/j.1532-5415.2012.
03905.x
25. Chen L, Reed C, Happich M, Nyhuis A, Lenox-Smith A. Health care resource
utilisation in primary care prior to and after a diagnosis of Alzheimer’s
disease: a retrospective, matched case-control study in the United Kingdom.
BMC Geriatr 2014;14:76. https://doi.org/10.1186/1471-2318-14-76.
26. Cortes F, Nourhashémi F, Guérin O, Cantet C, Gillette-Guyonnet S, Andrieu S,
et al. Prognosis of Alzheimer’s disease today: a two-year prospective study
in 686 patients from the REAL-FR study. Alzheimers Dement. 2008;4:22–9.
https://doi.org/10.1016/j.jalz.2007.10.018.
27. Hill J, Fillit H, Shah SN, Del Valle MC, Futterman R. Patterns of healthcare
utilization and costs for vascular dementia in a community-dwelling
population. J Alzheimers Dis. 2005;8:43–50. https://doi.org/10.3233/JAD-
2005-8105.
28. Jennings LA, Laffan AM, Schlissel AC, Colligan E, Tan Z, Wenger NS, et al.
Health Care Utilization and Cost Outcomes of a Comprehensive Dementia
Care Program for Medicare Beneficiaries. JAMA Intern Med. 2019;179:161–6.
https://doi.org/10.1001/jamainternmed.2018.5579.
29. Kunik ME, Snow AL, Molinari VA, Menke TJ, Souchek J, Sullivan G, et al.
Health care utilization in dementia patients with psychiatric comorbidity.
Gerontologist. 2003;43:86–91.
30. Malone DC, McLaughlin TP, Wahl PM, Leibman C, Arrighi HM, Cziraky MJ, et
al. Burden of Alzheimer’s disease and association with negative health
outcomes. Am J Manag Care. 2009;15:481–8.
31. Maust D, Kales H, McCammon R, Blow F, Leggett A, Langa K. Distress
Associated with Dementia-Related Psychosis and Agitation in Relation to
Healthcare Utilization and Costs. Am J Geriatr Psychiatry 2017;25:1074–82.
https://doi.org/10.1016/j.jagp.2017.02.025.
32. Miu D, Ying K, Hk M, Uk M, Cuhk MPH, Edin F, et al. Hospital admission risk
in community dwelling elderly dementia subjects. 2018;9:39–43. https://doi.
org/10.24816/jcgg.2018.v9i2.02
33. Mueller C, Perera G, Rajkumar A, Bhattarai M, Price A, O’Brien J, et al.
Hospitalization in people with dementia with Lewy bodies: Frequency,
duration, and cost implications. Alzheimer’s Dement Diagnosis, Assess Dis
Monit 2017;10:143–52. https://doi.org/10.1016/j.dadm.2017.12.001
34. Mueller C, Molokhia M, Perera G, Veronese N, Stubbs B, Shetty H, et al.
Polypharmacy in people with dementia: associations with adverse health
outcomes. Exp Gerontol. 2018;106:240–5. https://doi.org/10.1016/j.exger.
2018.02.011.
35. Nourhashemi F, Amouyal-Barkate K, Gillette-Guyonnet S, Cantet C, Vellas B.
Living alone with Alzheimer’s disease: cross-sectional and longitudinal
analysis in the REAL.FR study. J Nutr Health Aging. 2005;9:117–20.
36. Phelan EA, Borson S, Grothaus L, Balch S, Larson EB. Association of incident
dementia with hospitalizations. JAMA 2012;307:165–72. https://doi.org/10.
1001/jama.2011.1964
37. Rudolph J, Zanin N, Jones R, Marcantonio E, Fong T, Yang F, et al.
Hospitalization in community-dwelling persons with Alzheimer’s disease:
frequency and causes. J Am Geriatr Soc. 2010;58:1542–8. https://doi.org/10.
1111/j.1532-5415.2010.02924.x.
38. Russ T, Parra M, Lim A, Law E, Connelly P, Starr J. Prediction of general
hospital admission in people with dementia: cohort study. Br J Psychiatry.
2015;206:153–9. https://doi.org/10.1192/bjp.bp.113.137166.
39. Sköldunger A, Fastbom J, Wimo A, Fratiglioni L, Johnell K. Impact of
inappropriate drug use on hospitalizations, mortality, and costs in older
persons and persons with dementia: findings from the SNAC Study. Drugs
Aging. 2015;32:671–8. https://doi.org/10.1007/s40266-015-0287-4.
40. Sloane P, Schifeling C, Beeber A, Ward K, Reed D, Gwyther L, et al. New or
worsening symptoms and signs in community-dwelling persons with
dementia: incidence and relation to use of acute medical services. J Am
Geriatr Soc. 2017;65:808–14. https://doi.org/10.1111/jgs.14672.
41. Sommerlad A, Perera G, Mueller C, Singh-Manoux A, Lewis G, Stewart R, et
al. Hospitalisation of people with dementia: evidence from English
electronic health records from 2008 to 2016. Eur J Epidemiol. 2019. https://
doi.org/10.1007/s10654-019-00481-x.
42. Soto M, Andrieu S, Gares V, Cesari M, Gillette-Guyonnet S, Cantet C, et al.
Living alone with alzheimer’s disease and the risk of adverse outcomes:
Shepherd et al. BMC Medicine          (2019) 17:130 Page 12 of 13
Results from the plan de soin et d’aide dans la maladie d’alzheimer study. J
Am Geriatr Soc. 2015;63:651–8. https://doi.org/10.1111/jgs.13347
43. Tolppanen A-M, Taipale H, Purmonen T, Koponen M, Soininen H,
Hartikainen S. Hospital admissions, outpatient visits and healthcare costs of
community-dwellers with Alzheimer’s disease. Alzheimers Dement. 2015;11:
955–63. https://doi.org/10.1016/j.jalz.2014.10.005.
44. Zhao Y, Kuo T-C, Weir S, Kramer MS, Ash AS. Healthcare costs and utilization
for Medicare beneficiaries with Alzheimer’s. BMC Health Serv Res. 2008;8:
108. https://doi.org/10.1186/1472-6963-8-108.
45. Zhu C, Cosentino S, Ornstein K, Gu Y, Andrews H, Stern Y. Use and
cost of hospitalization in dementia: longitudinal results from a
community-based study. Int J Geriatr Psychiatry. 2015;30:833–41. https://
doi.org/10.1002/gps.4222.
46. Axmon A, Karlsson B, Ahlstrom G. Health care utilisation among older
persons with intellectual disability and dementia: a registry study. J Intellect
Disabil Res. 2016;60:1165–77. https://doi.org/10.1111/jir.12338.
47. Chen YH, Ho CH, Huang CC, Hsu YW, Chen YC, Chen PJ, et al. Comparison
of healthcare utilization and life-sustaining interventions between elderly
patients with dementia and those with cancer near the end of life: a
nationwide, population-based study in Taiwan. Geriatr Gerontol Int. 2017;17:
2545–51. https://doi.org/10.1111/ggi.13084.
48. Forma L, Rissanen P, Aaltonen M, Raitanen J, Jylhä M. Dementia as a
determinant of social and health service use in the last two years of life 1996–
2003. BMC Geriatr. 2011;11:14. https://doi.org/10.1186/1471-2318-11-14.
49. Kedia S, Chavan P, Boop S, Yu X. Health Care Utilization Among Elderly
Medicare Beneficiaries With Coexisting Dementia and Cancer. Gerontol
Geriatr Med. 2017;3:233372141668904. https://doi.org/10.1177/
2333721416689042.
50. Tian H, Abouzaid S, Sabbagh M, Chen W, Gabriel S, Kahler K, et al. Health
care utilization and costs among patients with AD with and without
dysphagia. Alzheimer Dis Assoc Disord. 2013;27:138–44. https://doi.org/10.
1097/WAD.0b013e318258cd7d.
51. Zhu CW, Scarmeas N, Ornstein K, Albert M, Brandt J, Blacker D, et al. Health-
care use and cost in dementia caregivers: longitudinal results from the
Predictors Caregiver Study. Alzheimers Dement. 2015;11:444–54. https://doi.
org/10.1016/j.jalz.2013.12.018.
52. Bynum J, Rabins P, Weller W, Niefeld M, Anderson G, Wu A, et al. Illness,
Medicare expenditures, and hospital use. J Am Geriatr Soc. 2004;52:187–94.
https://doi.org/10.1111/j.1532-5415.2004.52054.x.
53. Mann C. Observational research methods. Research design II: cohort, cross
sectional, and case-control studies. EMJ. 2003:54–60.
54. Brilleman SL, Pachana NA, Dobson AJ. The impact of attrition on the
representativeness of cohort studies of older people. BMC Med Res
Methodol. 2010;10. https://doi.org/10.1186/1471-2288-10-71.
55. Imison C, Poteliakhoff E, Thompson J. Older people and emergency bed
use. Exploring variation. Ideas That Chang Healthc. 2012:1–24. https://doi.
org/10.1136/emermed-2012-201867.
56. Toot S, Devine M, Akporobaro A, Orrell M. Causes of hospital admission for
people with dementia: a systematic review and meta-analysis. J Am Med
Dir Assoc. 2013;14:463–70. https://doi.org/10.1016/j.jamda.2013.01.011.
57. Pérez T, Moriarty F, Wallace E, McDowell R, Redmond P, Fahey T. Prevalence
of potentially inappropriate prescribing in older people in primary care and
its association with hospital admission: longitudinal study. BMJ. 2018;363:
k4524. https://doi.org/10.1136/BMJ.K4524.
58. Shi S, Mörike K, Klotz U. The clinical implications of ageing for rational drug
therapy. Eur J Clin Pharmacol. 2008;64:183–99. https://doi.org/10.1007/
s00228-007-0422-1.
59. Herrlinger C, Klotz U. Drug metabolism and drug interactions in the elderly.
Bailliere’s Best Pract Res Clin Gastroenterol. 2001;15:897–918. https://doi.org/
10.1053/bega.2001.0249.
60. Martin P, Tamblyn R, Benedetti A, Ahmed S, Tannenbaum C. Effect of a
pharmacist-led educational intervention on inappropriate medication
prescriptions in older adults. JAMA. 2018;320:1889. https://doi.org/10.1001/
jama.2018.16131.
61. Holm B, Söderhamn O. Factors associated with nutritional status in a group
of people in an early stage of dementia. Clin Nutr. 2003;22:385–9. https://
doi.org/10.1016/S0261-5614(03)00035-9.
62. Clague F, Mercer SW, Mclean G, Reynish E, Guthrie B. Comorbidity and
polypharmacy in people with dementia: insights from a large, population-
based cross-sectional analysis of primary care data. Age Ageing. 2017;46:33–9.
https://doi.org/10.1093/ageing/afw176.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Shepherd et al. BMC Medicine          (2019) 17:130 Page 13 of 13
